Three differentiation states risk-stratify bladder cancer into distinct subtypes
Top Cited Papers
Open Access
- 6 February 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (6), 2078-2083
- https://doi.org/10.1073/pnas.1120605109
Abstract
Current clinical judgment in bladder cancer (BC) relies primarily on pathological stage and grade. We investigated whether a molecular classification of tumor cell differentiation, based on a developmental biology approach, can provide additional prognostic information. Exploiting large preexisting gene-expression databases, we developed a biologically supervised computational model to predict markers that correspond with BC differentiation. To provide mechanistic insight, we assessed relative tumorigenicity and differentiation potential via xenotransplantation. We then correlated the prognostic utility of the identified markers to outcomes within gene expression and formalin-fixed paraffin-embedded (FFPE) tissue datasets. Our data indicate that BC can be subclassified into three subtypes, on the basis of their differentiation states: basal, intermediate, and differentiated, where only the most primitive tumor cell subpopulation within each subtype is capable of generating xenograft tumors and recapitulating downstream populations. We found that keratin 14 (KRT14) marks the most primitive differentiation state that precedes KRT5 and KRT20 expression. Furthermore, KRT14 expression is consistently associated with worse prognosis in both univariate and multivariate analyses. We identify here three distinct BC subtypes on the basis of their differentiation states, each harboring a unique tumor-initiating population.Keywords
This publication has 36 references indexed in Scilit:
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like stateProceedings of the National Academy of Sciences, 2011
- Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer ProgressionThe American Journal of Pathology, 2011
- A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessmentThe Lancet Oncology, 2011
- Cancer stem cells in bladder cancer: a revisited and evolving conceptCurrent Opinion in Urology, 2010
- MiDReG: A method of mining developmentally regulated genes using Boolean implicationsProceedings of the National Academy of Sciences, 2010
- Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell developmentGenes & Development, 2009
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial CarcinomaThe International Journal of Cell Cloning, 2009
- Regional copy number–independent deregulation of transcription in cancerNature Genetics, 2006
- Purification and unique properties of mammary epithelial stem cellsNature, 2006